Explore the two‑way link between low‑density lipoprotein and inflammation, how they spark atherosclerosis, and what lifestyle or medical steps can break the cycle.
Can Empagliflozin Prevent Type2 Diabetes in High‑Risk People?
Explore whether empagliflozin, an SGLT2 inhibitor, can stop type2 diabetes in people at high risk, reviewing trial data, mechanisms, and practical considerations.